HLB Group acquires ANYGEN to boost GLP-1 obesity treatment development HLB Group enhances peptide capabilities through ANYGEN ...

The solid-phase peptide synthesis (SPS) method involves fixing the first amino acid of GLP-1 on a polymer and covering the N-terminal with a protecting agent to prevent self-reactions. Thereafter ...

CordenPharma is making a record investment of >€1 billion over the next 3 years in building and / or expanding small, medium, ...

Cambridge synthetic biology doyen Constructive Bio has been awarded a significant grant from Innovate UK to transform the ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

After earmarking a major chunk of change last year to bulk up in peptide production, European CDMO CordenPharma is putting ...

CordenPharma has finalized plans to establish a new peptide manufacturing facility in Switzerland located at Getec Park in ...

Discover how peptides are transforming medical treatments, metabolic conditions and more with fewer side effects than ...

Metabolic-dysfunction-associated steatotic liver disease (MASLD) arises from excessive intrahepatic triglyceride accumulation ...

Hyderabad: Granules India Limited has announced the signing of the acquisition agreement regarding Senn Chemicals AG, a Swiss-based CDMO specializing in peptides.Senn develops and ...